Abstract:Pharmacokinetics and tissue distribution experiments were conducted in pigs to which sulphadimidine (SDM) was administered intravenously, orally, and intramuscularly at a dosage of 20 mg SDM/kg. SDM was acetylated extensively, but neither hydroxy metabolites nor their derivatives could be detected in plasma, edible tissues or urine. Following i.v. and two oral routes of administration, the N4-acetylsulphadimidine (N4-SDM) concentration-time curve runs parallel to that of SDM. The percentage of N4-SDM in plasma… Show more
“…Compared with the tissue-urine ratios, the tissue-plasma ratios showed less variation. This was also observed by Nouws et al (1986a) and Randecker et al (1987).…”
“…Compared with the concentrations in the tissue samples, the concentration in plasma was 2-4 times higher. This compares with the results of Nouws et al (1986a) in which they found that the sulphamethazine concentration in muscle, liver and kidney ranged from one-third to one fifth of that in plasma. It was noticeable that between the mean sulphamethazine concentrations in tissue and plasma obtained after 4 days versus 7 days drug withdrawal, no obvious differences were observed (see table 1).…”
“…An inhibition zone with a diameter of 20 mm (including the disc with a diameter of 12-7 mm) is applied as the action level. At inhibition zones of <20mm obtained with the NDKT with plasma, urine and renal pelvis fluid examination, the level in tissues should be less than 200 ug/kg for sulphamethazine and less than 100 ug/kg for sulphadimethoxine, sulphadiazine and sulphadoxine (Nouws et al 1986a(Nouws et al , 1988. In practice, the inhibition zone obtained with renal pelvis fluid is used as a predictor of sulphonamide levels in swine tissues.…”
The potential of an enzyme immunoassay (EIA) with high cross-reactivity towards the major metabolite (N4-acetyl-sulphamethazine) of sulphamethazine was tested for screening fluids and tissues. Healthy pigs were given 20 mg sulphamethazine per kg body weight per day in their drinking water for 2 days. Groups of four pigs were slaughtered after 3, 4 and 7 days withdrawal. The results were compared with liquid chromatographic analysis for urine, plasma, kidney, liver, gluteal muscle and diaphragm. In general, concentrations found by the EIA were higher than those found by liquid chromatography (LC) because sulphamethazine metabolites were detected by the EIA and not by LC. Using the EIA for the detection of sulphamethazine and the major metabolite in urine and plasma, predictive relationships (tissue-fluid ratios) for the concentration of the parent drug in tissue, determined by LC, were calculated. The tissue-plasma ratios for muscle, liver and kidney were 0.1, 0.2 and 0.1, respectively. The tissue-urine ratios for muscle, liver and kidney were 0.02, 0.03 and 0.03, respectively. Owing to the higher concentration of the parent drug in both fluids, the presence of the major metabolite in urine and the sensitivity of the EIA, tissue can be screened for low concentrations of sulphamethazine.
“…Compared with the tissue-urine ratios, the tissue-plasma ratios showed less variation. This was also observed by Nouws et al (1986a) and Randecker et al (1987).…”
“…Compared with the concentrations in the tissue samples, the concentration in plasma was 2-4 times higher. This compares with the results of Nouws et al (1986a) in which they found that the sulphamethazine concentration in muscle, liver and kidney ranged from one-third to one fifth of that in plasma. It was noticeable that between the mean sulphamethazine concentrations in tissue and plasma obtained after 4 days versus 7 days drug withdrawal, no obvious differences were observed (see table 1).…”
“…An inhibition zone with a diameter of 20 mm (including the disc with a diameter of 12-7 mm) is applied as the action level. At inhibition zones of <20mm obtained with the NDKT with plasma, urine and renal pelvis fluid examination, the level in tissues should be less than 200 ug/kg for sulphamethazine and less than 100 ug/kg for sulphadimethoxine, sulphadiazine and sulphadoxine (Nouws et al 1986a(Nouws et al , 1988. In practice, the inhibition zone obtained with renal pelvis fluid is used as a predictor of sulphonamide levels in swine tissues.…”
The potential of an enzyme immunoassay (EIA) with high cross-reactivity towards the major metabolite (N4-acetyl-sulphamethazine) of sulphamethazine was tested for screening fluids and tissues. Healthy pigs were given 20 mg sulphamethazine per kg body weight per day in their drinking water for 2 days. Groups of four pigs were slaughtered after 3, 4 and 7 days withdrawal. The results were compared with liquid chromatographic analysis for urine, plasma, kidney, liver, gluteal muscle and diaphragm. In general, concentrations found by the EIA were higher than those found by liquid chromatography (LC) because sulphamethazine metabolites were detected by the EIA and not by LC. Using the EIA for the detection of sulphamethazine and the major metabolite in urine and plasma, predictive relationships (tissue-fluid ratios) for the concentration of the parent drug in tissue, determined by LC, were calculated. The tissue-plasma ratios for muscle, liver and kidney were 0.1, 0.2 and 0.1, respectively. The tissue-urine ratios for muscle, liver and kidney were 0.02, 0.03 and 0.03, respectively. Owing to the higher concentration of the parent drug in both fluids, the presence of the major metabolite in urine and the sensitivity of the EIA, tissue can be screened for low concentrations of sulphamethazine.
“…In the absence of nitrate or nitrite, the plasma concentrations of SDM and N4-acetyl-SDM were similar to those previously reported by other authors (4,8).…”
The in vivo interaction of sulphadimidine (SDM) with nitrite and nitrate has been investigated in pigs. It was shown that the combined oral treatment with SDM and nitrite but not nitrate leads to the formation of a deaminated compound, which becomes the major metabolite in plasma soon after cessation of the treatment. The major in vitro reaction product, I,3-di(4-[N (4,6-dimethyl-2-pyrimidinyl)]-sulphamoylphenyl)-triazene, DDPSPT as has been reported previously, could not be detected in blood, urine or faeces of the exposed animals. No effect of nitrite or nitrate could be observed on the acetylation of SDM.
“…Sulfamethazine is known to undergo metabolism to mainly form N 4 -acetyl-SM 2 in numerous species of domestic animals, including fish and humans (10)(11)(12)(13)(14). Metabolic alteration of the parent compound by fish to more polar species or to less polar species can have an impact upon bioconcentration (5), so N 4 -acetyl-SM 2 , which is less polar than SM 2 , was used as a biodegradation marker of the drug in the test organism.…”
A steady-state bioconcentration and elimination of sulfamethazine (SM2) in the sturgeon (A. schrenkii) was conducted in flow-through aqueous conditions. Two treated groups of fish were exposed to concentrations of 1.00 and 0.10 mg/L of SM2, respectively. SM2 and its main metabolite, N4-acetyl-SM2, were determined in both fish muscle and water during the 8-day uptake period and the subsequent 6-day elimination period. Rapid uptakes of the drug were observed in both treated groups. Muscle tissue residues plateaued after ∼3 days. The bioconcentration factor in muscle (BCFm) in the low-concentration drug solution was 1.19 and that in the high-concentration-treated level was 0.61. The calculated biodegradation index was 3.72%. The elimination half-times (t1/2) of the two treatment levels were 19.44 and 23.52 h, respectively. The result indicates that SM2 will neither bioconcentrate in individual aquatic organisms nor biomagnify in the food chain, although the BCFm was relatively higher under the low-concentration exposure. A steady-state bioconcentration and elimination of sulfamethazine (SM 2 ) in the sturgeon (A. schrenkii) was conducted in flow-through aqueous conditions. Two treated groups of fish were exposed to concentrations of 1.00 and 0.10 mg/L of SM 2 , respectively. SM 2 and its main metabolite, N 4 -acetyl-SM 2 , were determined in both fish muscle and water during the 8-day uptake period and the subsequent 6-day elimination period. Rapid uptakes of the drug were observed in both treated groups. Muscle tissue residues plateaued after ∼3 days. The bioconcentration factor in muscle (BCF m ) in the low-concentration drug solution was 1.19 and that in the high-concentration-treated level was 0.61. The calculated biodegradation index was 3.72%. The elimination half-times (t 1/2 ) of the two treatment levels were 19.44 and 23.52 h, respectively. The result indicates that SM 2 will neither bioconcentrate in individual aquatic organisms nor biomagnify in the food chain, although the BCF m was relatively higher under the low-concentration exposure.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.